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Background: Medicare’s mandatory bundle for hip and knee arthroplasty necessitates provider
accountability for quality and cost of care to 90 days, and wound closure may be a key area of
consideration. The DERMABOND® PRINEO® Skin Closure System (22 cm) combines a topical skin adhesive with a self-adhering mesh without the need for dressing changes or suture or
staple removal. This study estimated the budget impact of the Skin Closure System compared
to other wound closure methods for hip and knee arthroplasty.
Methods: A 90-day economic model was developed assuming 500 annual hip/knee arthroplasties for a typical US hospital setting. In current practice, wound closure methods for the final
skin layer were set to 50% sutures and 50% staples. In future practice, this distribution shifted
to 20% sutures, 20% staples, and 60% Skin Closure System. Health care resources included
materials (eg, staplers, steri-strips, and traditional/barbed sutures), standard or premium dressings, outpatient visits, and home care visits. An Expert Panel, comprised of three orthopedic
physician assistants, two orthopedic surgeons, and a home health representative, was used to
inform several model parameters. Other inputs were informed by national data or literature.
Unit costs were based on list prices in 2016 US dollars. Uncertainty in the model was explored
through one-way sensitivity and alternative scenario analyses.
Results: The analysis predicted that use of Skin Closure System in the future practice could
achieve cost savings of $56.70 to $79.62 per patient, when standard or premium wound dressings are used, respectively. This translated to an annual hospital budgetary savings ranging from
$28,349 to $39,809 when assuming 500 arthroplasties. Dressing materials and postoperative
health care visits were key model drivers.
Conclusions: Use of the Skin Closure System may provide cost savings within hip and knee
arthroplasties due to decreases in resource utilization in the postacute care setting.
Keywords: budget impact analysis, wound closure, knee arthroplasty, hip arthroplasty, hospital,
economic, wound dressings, costs, postacute care
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Wound complications are one of the major sources of morbidity and costs related
to arthroplasty procedures, including dehiscence, infection, inflammation, necrosis,
abscess, and blistering.1–4 Surgical site complications (including infection, dehiscence, and disruption) have been reported as a key reason for readmissions, with over
30% of 30-day readmissions in total hip arthroplasty and total knee arthroplasty.5–9
Alone, surgical site infections (SSIs) are associated with serious outcomes, such as
increased mortality and pose a significant economic burden.5 Another factor potentially
impacting the occurrence of wound complications is wound perfusion.10 Depending
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on the method used for arthroplasty closure, perfusion and
subsequent wound healing can either be improved (ie, using
running sutures) or hindered (ie, using staples).10
In addition to current methods of wound closure such as
sutures or staples, wound dressings are necessary for proper
wound management.11 However, wound dressings are not
intended for wound closure and therefore lack the required
strength. In addition, several wound dressings require dressing changes which can be painful, time-consuming, increase
pathogen exposure, and delay wound healing.11,12 In hip
and knee arthroplasty, wound dressings are reported to be
typically changed three to five times on average, which can
impose a significant cost burden.4,13
The DERMABOND® PRINEO® Skin Closure System
(22 cm) (Ethicon U.S., LLC, Somerville, NJ, USA) (ie, Skin
Closure System) is a novel skin closure device that combines
a topical skin adhesive (TSA) (2-octyl cyanoacrylate) with a
self-adhering mesh.14 This design provides a wound closure
method without the need for dressing changes. Also, the
Skin Closure System has been proved to be 99% effective
through 72 hours in vitro as a microbial barrier against
bacteria most commonly associated with SSI, including
Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Enterococcus faecium, and Staphylococcus
epidermidis.15 Four randomized trials have evaluated the Skin
Closure System across a variety of surgery types.16–19 These
randomized studies have demonstrated comparable wound
closure efficacy16,17 and lower skin closure and procedure time
relative to sutures.16–18 Furthermore, the Skin Closure System
has also been shown to provide good cosmetic results up to
1 year,16–18 less pain at removal compared to other wound
closure methods,18 and the ability for patients to shower
immediately after procedure if directed by their health care
practitioner.18 The TSA c omponent has also been extensively
studied in over 40 randomized trials, including within hip
and knee arthroplasty.20–23
Recently, the Centers for Medicare & Medicaid Services
(CMS) implemented the first mandatory bundle for hip and
knee arthroplasty in 67 regions across the USA, which necessitates provider accountability for quality and cost of care
to 90 days.24,25 Within the context of this health care reform
environment, decision makers need to consider products that
provide the best clinical outcomes, while balancing budgets.
As such, the objective of this study was to conduct a 90-day
budget impact analysis from the hospital provider perspective of the Skin Closure System compared with other wound
closure methods (ie, sutures and staples) for hip and knee
arthroplasty in the USA.
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Methods
Model design
A budget impact model with a 90-day time horizon was developed using Microsoft Excel 2013 (Microsoft Corporation,
Redmond, WA, USA) to estimate the total costs of wound
closure methods for final skin layer closure in hip and knee
arthroplasty procedures from a US hospital provider perspective, including acute and postacute care. The model assumed
that 500 hip and knee arthroplasty procedures are performed
annually at a facility. The model was developed in accordance
with recommendations from the International Society for
Pharmacoeconomics and Outcomes Research (ISPOR) Task
Force Report: Budget Impact Analysis whenever possible.26
The model compared final skin layer wound closure materials, dressings, and postoperative visit costs between a current
and future scenario in hip and knee arthroplasty procedures.
The current scenario for wound closure methods primarily
comprised staples and sutures, while the future scenario
included the adoption of the Skin Closure System. In the
current scenario, the model specifically assumed 50% use of
staples and 50% use of sutures, as per US Premier Perspective®
Database findings.27 In the future scenario, the model assumed
60% of arthroplasties would be treated with the Skin Closure
System, 20% with staples, and 20% with sutures. Details of
all model input values are provided in Table 1.

Expert panel
In the published literature, there is a lack of information on
the steps involved in wound closure and postoperative care in
hip and knee arthroplasty. To obtain a detailed understanding
of these processes, expert opinion was sought. To characterize the treatment practices of wound closure care in hip and
knee arthroplasty, from beginning to end, a 31-item survey
was developed based on literature gaps and administered via
teleconference individually with each expert. Although the
survey is not a formally validated questionnaire, a face-toface meeting was held with the expert panel after the first
set of answers was obtained to help ensure face validity. The
panel consisted of two orthopedic surgeons, three physician
assistants that specialize in orthopedic surgeries, and one
home health agency representative. The panel was used to
determine typical resource use for hip and knee arthroplasty
procedures over a 90-day period for wound closure with
staples, sutures, or Skin Closure System. For the model, several inputs for wound closure materials, dressing materials,
and postoperative visits were informed by the panel. If variability existed in clinician responses, a mean value was used
where possible and variability tested in alternative scenarios.
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Table 1 Summary of model inputs by closure method for base case scenario: materials, dressings, and postoperative visits in 90 days
Model parameters

Staples

Materials used for final skin layer
Materials

Staples

Steri-strips

Traditional
suturea

Barbed
suture

Traditional
TSA

Primary
100
1.1
43.89

Optional
100
1.0
0.74

Primary
95
1.0
15.96

Primary
5
1.0
37.04

Optional
15.1
2.0
37.76

Standard
2.97
1.0
1.0
1.0
5.0
1.0

Premium
58.99
1.0
0
0
0
0

Standard
2.97
1.0
1.0
1.0
5.0
1.0

Classificationc
Proportion usec,27 (%)
Number of unitsc
Unit cost28 ($)
Dressing usage within 90 days
Dressing type
Unit cost31,32 ($)
Units for unitial dressing applicationc
Number of inpatient dressing changesc
Units per inpatient dressing changec
Number of outpatient dressing changesc
Units per outpatient dressing changec
Postoperative visits within 90 days
Outpatient visits
Visit cost29 ($)
Proportion of patients with visitsc (%)
Number of visits per patientc
Home health nurse visits
Visit cost30 ($)
Proportion of patients with visitsc (%)
Number of visits per patientc

Sutures

Skin Closure System

Premium
58.99
1.0
0
0
0
0

Skin
closure
system
Primary
100
1.0
140.92

Traditional
sutureb

Barbed
suture

Optional
45
1.0
15.44

Optional
5
1.0
37.04

The Skin Closure System does
not require dressings or dressing
changes

117.50
100
3

100
3

100
2

134.42
50
3

50
3

50
2

Notes: One base case scenario assumed standard dressings, whereas the other assumed premium dressings. aTraditional sutures included a combination of absorbable (ie,
monocryl) and nonabsorbable (ie, nylon) sutures. bTraditional sutures included only absorbable sutures (ie, monocryl) as nonabsorbable sutures are not compatible with the
Skin Closure System. cInputs determined by clinical opinion from Expert Panel.

Closure materials
Materials used for wound closure varied by closure method.
Each closure method consisted of a primary product, which
was used in all patients, and optional products that could
be used adjunctively. The proportion of use for primary or
optional materials was informed by the expert panel, analysis
from the Premier Perspectives® Database, or through model
assumptions.27 The number of units used for each product was
gathered from the expert panel. Unit costs were determined
from list prices.28 For closure with staples, the primary material was denoted to be a disposable stapler and the optional
material included steri-strips. The expert panel predicted that
90% of cases would require a single stapler, whereas 10% of
cases would require two, for a weighted average of 1.1 units
per procedure. Added to the cost of staples was a single unit
for a staple removal kit. The panel also determined all patients
receiving staples were assumed to use steri-strips, with only
a single package used each case.

ClinicoEconomics and Outcomes Research 2019:11

For closure with sutures, the panel identified the primary
materials to be traditional or barbed sutures and estimated
breakdown of use. Traditional sutures were assumed to be
used in 95% of cases and barbed sutures were used in the
remaining 5%, with one suture unit used for all types. Traditional sutures comprised absorbable (ie, monocryl) and nonabsorbable (ie, nylon) sutures. All traditional suture patients
were assumed to have absorbable sutures, with 5% of cases
additionally requiring adjunctive nonabsorbable sutures. For
optional materials, the panel identified TSAs as a potential
adjunctive treatment with traditional or barbed sutures. The
panel was not able to reach a consensus on the proportion
of TSA use, so the US Premier Perspectives® Database was
used to determine that 15.1% of suture cases require TSA.27
The panel estimated that an average of two TSA units are
used per procedure.
Closure with the Skin Closure System was estimated
to require one unit on average. For optional materials, the
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panel proposed sutures could be used adjunctively in 50% of
cases. Although closure with the Skin Closure System does
not require subcuticular suture use, the panel estimated that
some users would still place these sutures, especially in higher
tension knee procedures. It was further assumed that of suture
use, 90% would involve traditional sutures (absorbable only,
as nylon sutures cannot be used with Skin Closure System)
and 10% would involve barbed sutures, with one unit used
on average for either suture type.

Postoperative visits
The model considered postoperative costs over the 90-day
period with the types of visits impacted by wound closure
method being identified by the panel of experts. These
included outpatient and home health nurse visits.
For outpatient visits, the panel agreed all patients would
return for an average of 3 visits during the 90-day period
with staples or sutures. This consisted of a visit at: 2 weeks,
6 weeks, and 3 months. The panel predicted that the use
of the Skin Closure System as the primary wound closure
method could reduce the number of visits by one visit. With
outpatient visits, the cost per visit was assumed to be the
same regardless of wound closure method and was calculated
from the literature (cost per physician office visits during
peri-operative period).29
With home health nursing visits, the panel was not able to
estimate the proportion of arthroplasty patients receiving this
service. The panel noted that hospitals would either have all
patients or no patients receive home nursing care. The model
default used the average as an assumption, with 50% of patients
receiving home health visits during the 90-day follow-up. Similarly for outpatient visits, the panel estimated that the number
of home health nursing visits during the 90-day period would
be 3 on average for staples and sutures. This number could be
reduced by one visit with the use of the Skin Closure System
as the primary wound closure method. The cost of health nurse
visits was taken from the Low Utilization Payment Adjustment
rate for skilled nursing as reported by CMS.30

Dressing materials
The panel confirmed that wound dressings are commonly
used following hip and knee arthroplasties. The model
assumed dressings were required for all patients receiving staples or sutures for wound closure and that dressings
were not required for patients treated with the Skin Closure
System, as per its instruction for use.14 The panel identified
that dressings could be used at different stages throughout
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the 90-day follow-up period, including: 1) the initial application after the arthroplasty procedure; 2) applications during
inpatient stay; and 3) applications during outpatient care.
The number of dressings used, and the frequency of dressing
changes were assumed to depend on the type of dressing.
The types of dressings were classified into two categories:
standard and premium.
Standard dressings were assumed to be simple wound
closure products, such as generic 4×4 gauze pads. The panel
estimated that these products required a single unit during
each application and that there was one dressing change
during inpatient stay as well as 5 dressing changes in an outpatient setting. Premium dressings were assumed to be more
advanced products that may possess antimicrobial properties.
The panel further estimated that these products required a
single unit during the initial application and required no
dressing changes during inpatient stay or outpatient setting. Unit costs for standard and premium dressings were
taken from RED BOOK Online average wholesale prices
for Tegaderm™ HP Transparent Dressing and Aquacel® Ag
Surgical Hydrofiber, respectively.31,32
The panel could not estimate the proportion of cases
where standard vs premium dressings were utilized. Based
on this, two analyses were modeled, one where only standard
dressings were used and the other where only premium dressings were used (all other inputs relating to wound closure and
postoperative care were identical between the two analyses).

Modeled analysis
Two base case (ie, most likely) scenarios were analyzed using
model input values from Table 1. The distinction between the
two scenarios was that one included only standard dressings
and the other included only premium dressings. For each of
the base case scenarios, several one-way sensitivity analyses
were performed by increasing or decreasing the default model
input values, one parameter type at a time, by 20%.
Several additional scenarios, some of which varied multiple inputs at a time, were also modeled to test potential
variations in current market-share as well as uptake rates
of the Skin Closure System (see Table 2). Extreme values
for certain treatment practices were also tested in scenario
analyses. This included the assumption of no difference in
the number of outpatient visits, home health nurse visits, or
both (multi-way), between comparators. Scenarios were also
evaluated which assumed that either 0% or 100% of patients
received home health nurse visits, as this practice is expected
to dichotomously vary across settings.

ClinicoEconomics and Outcomes Research 2019:11
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of $39,809 ($79.62 per patient) was predicted. In both analyses, the increased wound closure material costs were offset
by reductions in the costs associated with dressing materials
and postoperative visits (Figure 1; Table 3).

Assuming 500 annual hip and knee arthroplasty procedures,
the model predicted that a 60% uptake of the Skin Closure
System could be cost saving to the hospital provider, regardless of the type of wound dressing (ie, standard or premium)
used in the facility. Specifically, the model predicted that a
facility using standard (low-cost) dressings may anticipate
annual savings of $28,349 ($56.70 per patient). When a facility uses premium (higher-cost) dressings, an annual savings

Sensitivity analysis results
The results of the one-way sensitivity analysis, where
parameters were varied by 20%, are presented in Figure 2.
The model conclusions remained robust, with cost savings
predicted across all scenarios tested. The results were most

Table 2 Market-share scenarios for base case and alternative scenario analyses
Cost types

Staples

Base case analysis
Alternative Scenario 1
Alternative Scenario 2
Alternative Scenario 3

A

Sutures

Skin Closure System

Current (%)

Future (%)

Current (%)

Future (%)

Current (%)

Future (%)

50
50
100
0

20
0
0
0

50
50
0
100

20
0
0
0

0
0
0
0

60
100
100
100

$350,000

Total incremental costs

$300,000

Postoperative visit costs

$250,000

Dressing costs
Closure material costs

$200,000
Total cost
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Results
Base case scenario

$150,000
$100,000
$50,000
$0
–$50,000

B

Current practice

Future practice

Incremental

$350,000
$300,000
$250,000

Total incremental costs
Postoperative visit costs

Total cost

$200,000

Dressing costs

$150,000

Closure material costs

$100,000
$50,000
$0
–$50,000
–$100,000

Current practice

Future practice

Incremental

Figure 1 Graphical summary of 90-day wound closure-related cost results for 500 hip and knee arthroplasty procedures in a current vs future scenario.
Notes: Results are provided for both standard dressing (A) and premium dressing analysis (B). A negative value indicates cost savings for future vs current scenario.
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Table 3 Detailed summary of 90-day wound closure-related cost results for 500 hip and knee arthroplasty procedures in a current
vs future scenario
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Cost types
Standard dressing
Closure material
Dressing material
Postoperative visit
Total cost per population
Premium dressing
Closure material
Dressing material
Postoperative visit
Total cost per population

Current scenario costs ($)a

Future scenario costs ($)b

Incremental

19,359
10,395
277,065
306,819

52,660
4,158
221,652
278,470

33,301
−6,237
−55,413
−28,349

19,359
29,495
277,065
325,919

52,660
11,798
221,652
286,110

33,301
−17,697
−55,413
−39,809

Notes: Results are provided for both standard dressing and premium dressing analysis. Negative values indicate cost savings for the future vs current scenario analysis.
a
Assumes 50% use of both sutures and staples.27 bAssumes 20% suture use, 20% staple use, and 60% Skin Closure System use.

Total incremental cost

A

–$40,000

–$30,000

–$20,000

–$10,000

$0

Skin Closure System units
Skin Closure System cost
Outpatient visit cost
Outpatient visit units
Home health nurse visit units
Home health nurse visit cost
Staples cost
Staples units
Dressing units
Dressing cost
Suture units
Suture cost

B

Total incremental cost
–$60,000

–$50,000

–$40,000

–$30,000

–$20,000

–$10,000

$0

Skin Closure System units
Skin Closure System cost
Outpatient visit cost
Outpatient visit units
Home health nurse visit units
Home health nurse visit cost
Dressing cost
Dressing units
Staples cost
Staples units
Suture units
Suture cost
Figure 2 One-way sensitivity results on the base case analysis for standard dressings (A) and premium dressings (B) for 500 hip and knee arthroplasty procedures. A negative
value indicates cost savings for future vs current scenario.
Note: The center line represents the base case incremental cost between the current and future analysis scenarios.
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sensitive to changes in the number of units or unit costs of
the Skin Closure System. Results were also sensitive to the
number and costs of health care visits. As demonstrated by
the bottom of the tornado diagram, results were least sensitive to changes in the number of units and costs of staples
and sutures.
Of the 16 alternative scenarios tested, 13 were predicted
to be cost saving (Figure 3). For the market-share scenarios,
increasing the adoption of the Skin Closure System was
predicted to increase cost savings to the hospital provider,
irrespective of whether sutures or staples were the main
comparator. For health care visit scenarios, the presence or
absence of home nurse visits as part of a hospital protocol
did not change the directionality of the results. Results were
sensitive to whether differences in health care visits (ie,
outpatient or home health nurse) between comparators were
assumed, particularly when assuming no difference in both
outpatient visits and home health nursing visits. However,

A

Total incremental cost

in the scenarios that predicted a cost impact with increased
adoption of the Skin Closure system, cost offsets were still
seen, with the increased material costs associated with use
of the Skin Closure System being offset by reduced dressing costs.

Discussion
The model demonstrated that the adoption of a novel wound
closure device may provide important cost savings in hip and
knee arthroplasty procedures to hospital providers during the
critical 90-day postacute care period associated with bundled
payments. These findings are a result of reduced healthcare
resource utilization, particularly associated with dressing
changes and postacute care visits, with increased uptake of
the Skin Closure System relative to the current standard of
care of sutures and staples. Specifically, the model predicts
an annual cost savings of $28,349 to $39,809 per 500 hip or
knee arthroplasty related to wound closure and care-related

Market-share scenarios

$50,000

Health care visit scenarios

$25,000
$0
–$25,000
–$50,000
–$75,000

B

Base case

S1

S2

S3

Base case

S4

S5

S6

S7

S8

S8

$25,000
Total incremental cost
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$0
–$25,000
–$50,000
–$75,000
–$10,000

Base case

S1

Base case

S1

S2

S3

S2

S3

C

F

C

F

C

F

C

F

SCS (%)

0

60

0

100

0

100

0

100

Staples (%)

50

20

50

0

100

0

0

0

Sutures (%)

50

20

50

0

0

0

100

0

Base case

S4

S5

S6

S7

Base case

S4

S5

S6

S7

S8

Visit type

OP

HHN

OP

HHN

OP

HHN

OP

HHN

OP

HHN

OP

HHN

Patients (%)

100

50

100

50

100

50

100

50

100

0

100

100

SCS (n)

2

2

3

2

2

3

3

3

2

2

2

2

Staples (n)

3

3

3

3

3

3

3

3

3

3

3

3

Sutures (n)

3

3

3

3

3

3

3

3

3

3

3

3

Figure 3 Additional scenario results with standard dressings (A) and premium dressings (B) for 500 hip and knee arthroplasty procedures.
Notes: Scenario results report the incremental costs between current and future scenarios. A negative value indicates cost savings with the future scenario.
Abbreviations: C, current; F, future; HHN, home health nurse; OP, outpatient; S, scenario; SCS, Skin Closure System.
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costs when there is a 60% uptake of the Skin Closure System.
Our study further contributes to the literature by providing a
detailed hospital budget impact assessment of a novel device
in hip and knee arthroplasty as there is a dearth of economic
literature in this area.
As costs and practices can vary by hospital, a range of
sensitivity analyses and alternative scenarios were performed
to explore uncertainty within the model. One-way sensitivity
analyses highlighted that model results consistently showed
cost savings with increased uptake of the Skin Closure
System across upper and lower ranges of model parameters.
Additional scenario analyses explored variations in model
parameters that may reasonably vary across facilities in the
USA, including whether sutures, staples or both are used as
current practice, whether home health care visits by nurses
are part of standard hospital protocol, and the level of uptake
of the Skin Closure System in future practice. Many of these
alternative scenarios predicted similar results to the original
base case assumptions. Finally, several scenarios tested the
impact of reducing the benefit of the Skin Closure System
on outpatient and/or home health care nurse visits. In some
of these scenarios, the incremental results for the future vs
current scenario changed from cost saving to cost impact;
however, this largely occurred when it was conservatively
assumed that the Skin Closure System was associated with
no reduction in any type of visit. In these scenarios, the
increased costs associated with the Skin Closure System
were still offset due to reduced dressing-related costs. The
results of these analyses capture some of the potential variability in treatment patterns, resource use, and costs that may
occur across hospitals and demonstrate the robustness of the
economic benefits of the Skin Closure System.
According to Sharma et al, the ideal dressing for hip and
knee arthroplasty wounds is that the dressing should be able
to act as a microbial barrier while handling excess wound
exudate, enable freedom of movement, accommodate joint
flexion, enable wound visibility through the dressing, and
allow for atraumatic dressing changes and removal.33 The
Skin Closure System has several of these characteristics, that
is, it is capable of eliminating the need for dressing changes
altogether, and, unlike standard dressings, and is a method
for wound closure.34,35 Evidence has shown that products that
reduce the number of dressing changes may reduce costs even
with increased acquisition costs.36 As wound dressings typically need to be changed three to five times in arthroplasty,
reducing dressing changes saves material costs, staff time,
reduces the delay in cellular activity for wound healing, and
reduces the risk for pathogen exposure during the dressing
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changes.4,11,13 Reducing potential pathogen exposure can
have significant economic benefits by reducing the risk of
SSI, which is associated with total costs 3- to 4-fold higher
compared to procedures without SSIs.5,37,38 The Skin Closure
System provides additional benefits with its significantly
greater skin-holding strength and better tension distribution across the wound compared to staples or sutures.39,40
Additionally, the Skin Closure System provides a breadth of
patient benefits including the ability to shower immediately
following surgery if directed by their health care professional,
good cosmetic results, easy self-care since no postsurgical
dressings are needed, designed to provide microbial barrier
protection, no suture or staple removal, and less pain on
removal.14–18,35
Additional evidence has shown the ability of the Skin
Closure System to improve knee arthroplasty outcomes in
a clinical setting.41 In a recent retrospective study of 1,942
total knee arthroplasty patients, statistically significant reductions were reported in 30-, 60-, 90-day all cause readmission
rates, length of hospital stay, and probability of discharge to
a skilled nursing facility or other nonhome setting with the
Skin Closure System compared with skin staples.41 With a
30-day, all-cause readmission costing $12,839 and penalties
of up to 3% of total inpatient Medicare revenue for worsethan-average readmission rates for knee arthroplasty, these
results have important implications for total cost savings to
US hospitals.42–44 The findings from this study further support the results of our modeling work, indicating postacute
care sources of cost-savings with the Skin Closure System.
Given the current health care reform and bundled payment
initiatives established by CMS for hospital reimbursement
of hip and knee arthroplasty, the Skin Closure System offers
a unique opportunity to both reduce health care costs and
improve patient outcomes and satisfaction.24,25 With bundled
payment, hospitals are reimbursed at a flat rate per episode
of care as opposed to reimbursement based on the specific
treatments provided. This new system creates an incentive
for organizations to become more coordinated in providing
the best care possible to patients rather than focusing on the
quantity of services provided.45 In the context of all health
care reform programs collectively, the adoption of health care
technologies that are clinically superior, cost-effective, and
patient-focused is critical for hospitals to succeed in meeting
the principles of the Triple Aim: improve patient experience/
outcomes, improve health, and reduce costs.46
Despite efforts to accurately reflect clinical practices for
knee and hip arthroplasties, the model inputs are largely based
on clinical opinion from a panel of experts and therefore
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c aution must be taken in generalizing results across US provider situations. However, this methodology was necessary
given the lack of published information on the process of
wound closure care for these procedures. This need for caution is mitigated through the variability in experience among
panel members, as panel members included a mix of those
who currently do and do not use the Skin Closure System.
The numerous sensitivity and scenario analyses help address
this issue by accommodating the potential variety of provider
processes of care. The use of expert opinion and surveys is
also consistent with the ISPOR guidelines for determining
inputs relating to practice patterns.26 Additionally, the methods for obtaining information from the expert panel included
a very detailed and progressive set of steps to optimize the
completeness and accuracy of the data, including discussion
of survey questions during a teleconference as well as an
in-person meeting. Future research with an expanded set of
clinical experts across regions may help validate our findings.
A further limitation of the study was that the sensitivity
analyses used arbitrary thresholds of ±20% to assess impact
of lower and upper ranges on parameter values. However, due
to the limited literature available, considering the basis of
variation in the analysis on known alternative values was not
always possible. At a minimum, the use of this method is beneficial for identifying the most impactful parameters which
can inform decision-making. As well, additional scenario
analyses help to capture the range of variability in a different
way by testing the impact of model structural uncertainty and
potentially different hospital facility scenarios, such as with
the unknown uptake rates of the Skin Closure System. Both
one-way sensitivity analyses and scenario analyses on structural uncertainty are recommended when conducting budget
impact analyses.26 Another potential source of structural
uncertainty was regarding whether all possible parameters
were in fact included in the model. Due to limited data, certain
parameters, such as risk of infection, could not be modeled.
This analysis may therefore be considered conservative in
terms of the potential economic benefits the Skin Closure
System has relative to standard care. Further data on such
outcomes can help to complete the economic assessment of
this product in hip and knee arthroplasty.
The current study provides a novel perspective on the
cost analysis of hip and knee arthroplasty procedures not
currently found in the literature. Despite a wealth of research
on skin adhesives, staples and various types of sutures, very
little is available regarding devices such as the Skin Closure
System, and even less is available concerning their economic
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benefits. With the inclusion of all currently available cost
data in the model and the rigorous sensitivity and scenario
analyses conducted, this study demonstrated that the Skin
Closure System may have important economic benefits in
the postacute care setting.
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